US 2,003,232,410 Β· Filed 2003-03-20
Methods and compositions for using zinc finger endonucleases to enhance homologous recombination
Embodiments relate to methods of generating a genetically modified cell. The methods can include providing a primary cell containing an endogenous chromosomal target DNA sequence in which it is desired to have homologous recombination occur. The methods also can include providing a zinc finger endonuclease (ZFE) that includes an endonuclease domain that cuts DNA, and a zinc finger domain that includes a plurality of zinc fingers that bind to a specific nucleotide sequence within the endogenous chromosomal target DNA in the primary cell. Further, the methods can include contacting the endogenous chromosomal target DNA sequence with the zinc finger endonuclease in the primary cell such that the zinc finger endonuclease cuts both strands of a nucleotide sequence within the endogenous chromosomal target DNA sequence in the primary cell, thereby enhancing the frequency of homologous recombination in the endogenous chromosomal target DNA sequence. The methods also include providing a nucleic acid comprising a sequence homologous to at least a portion of said endogenous chromosomal target DNA such that homologous recombination occurs between the endogenous chromosomal target DNA sequence and the nucleic acid.
Patent details
- Publication number
- US 2,003,232,410
- Filing date
- 2003-03-20
- Grant date
- Application β not yet granted
- Assignee
- Monika Liljedahl / Aspland Simon Eric / Segal David J.
- Inventor(s)
- LILJEDAHL MONIKA, ASPLAND SIMON ERIC, SEGAL DAVID J.
- CPC class
- A01K67/0275
Want to file your own patent?
Run your idea through our free scanner β weβll show you which existing patents are conceptually closest, including this one if itβs a match.
Free patentability scanRelated patents in this cluster
- US 5,633,425: Transgenic non-human animals capable of producing heterologous antibodies
- US 5,545,807: Production of antibodies from transgenic animals
- US 5,661,016: Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
- US 6,075,181: Human antibodies derived from immunized xenomice